Inventor · disambiguated record
Gary A. Piazza
Also filed as: PIAZZA GARY · PIAZZA GARY A
79 granted patents·19 pending applications·1,812 citations·filing 1991–2022
99Inventor score
Files withCELL PATHWAYS INC53ADT PHARMACEUTICALS LLC8ADT PHARMACEUTICALS INC4PROCTER & GAMBLE4UNIV SOUTH ALABAMA3
Top patents by PatentIndex Score
98 records- 0196US10981886B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2019·Granted Apr 20, 2021·5 cites·15 claims
- 0296US10975054B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2019·Granted Apr 13, 2021·5 cites·17 claims
- 0396US6348032B1Method of inhibiting neoplastic cells with benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Feb 19, 2002·117 cites·2 claims
- 0495US11198679B2Method of treating or preventing Ras-mediated diseasesADT PHARMACEUTICALS LLC·Filed 2020·Granted Dec 14, 2021·3 cites·6 claims
- 0595US11130744B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2020·Granted Sep 28, 2021·3 cites·15 claims
- 0694US10526307B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2015·Granted Jan 7, 2020·11 cites·15 claims
- 0794US6046206AMethod of treating a patient having a precancerous lesions with amide quinazoline derivativesCELL PATHWAYS INC·Filed 1997·Granted Apr 4, 2000·150 cites·10 claims
- 0893US9931315B2Method of selectively inhibiting Ras-mediated tumor growth in humansADT PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·14 cites·3 claims
- 0993US8044048B2Derivatives of sulindac, use thereof and preparation thereofSOUTHERN RES INST·Filed 2007·Granted Oct 25, 2011·15 cites·33 claims
- 1093US5948911AMethod for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Sep 7, 1999·69 cites·19 claims
- 1192US6358992B1Method of inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1999·Granted Mar 19, 2002·125 cites·14 claims
- 1292US6200980B1Method of treating a patient having precancerous lesions with phenyl purinone derivativesCELL PATHWAYS INC·Filed 1997·Granted Mar 13, 2001·60 cites·8 claims
- 1391US11407727B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2020·Granted Aug 9, 2022·2 cites·6 claims
- 1491US9862698B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS INC·Filed 2014·Granted Jan 9, 2018·13 cites·19 claims
- 1591US6380206B1Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 30, 2002·35 cites·6 claims
- 1691US6133271AMethod for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Oct 17, 2000·92 cites·12 claims
- 1790US11104658B2Method of treating or preventing Ras-mediated diseasesADT PHARMACEUTICALS LLC·Filed 2015·Granted Aug 31, 2021·3 cites·8 claims
- 1890US6369092B1Method for treating neoplasia by exposure to substituted benzimidazole derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 9, 2002·32 cites·3 claims
- 1987US6166053ASubstituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 2000·Granted Dec 26, 2000·14 cites·2 claims
- 2086US6486158B1[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasiaCELL PATHWAYS INC·Filed 2001·Granted Nov 26, 2002·17 cites·33 claims
- 2186US6211177B1Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Apr 3, 2001·86 cites·6 claims
- 2284US11186534B2Derivatives of sulindac can protect normal cells against oxidative damageUNIV SOUTH ALABAMA·Filed 2018·Granted Nov 30, 2021·2 cites·28 claims
- 2384US5565439AMethods of using lysophosphatidic acid for treating hyperproliferative conditionsPROCTER & GAMBLE·Filed 1994·Granted Oct 15, 1996·73 cites·7 claims
- 2483US6420410B1Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-onesCELL PATHWAYS INC·Filed 2000·Granted Jul 16, 2002·17 cites·7 claims
- 2582US12479813B2Method of therapeutically treating cancerADT PHARMACEUTICALS LLC·Filed 2022·Granted Nov 25, 2025·0 cites·1 claims
- 2682US6403831B1Substituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 2000·Granted Jun 11, 2002·13 cites·1 claims
- 2782US6180629B1[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Jan 30, 2001·28 cites·24 claims
- 2880US6410584B1Method for inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1998·Granted Jun 25, 2002·46 cites·2 claims
- 2980US5858694AMethod for identifying compounds for inhibition of cancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jan 12, 1999·60 cites·26 claims
- 3079US6300346B1Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 2000·Granted Oct 9, 2001·7 cites·16 claims
- 3178US7115647B2Method of inhibiting neoplastic cells with indole derivativesOSI PHARM INC·Filed 2002·Granted Oct 3, 2006·6 cites·3 claims
- 3278US6262059B1Method of treating a patient having precancerous lesions with quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Jul 17, 2001·44 cites·19 claims
- 3376US5990117AMethod for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Nov 23, 1999·43 cites·10 claims
- 3476US5965619AMethod for treating patients having precancerous lesions with substituted indene derivativesCELL PATHWAYS INC·Filed 1997·Granted Oct 12, 1999·47 cites·29 claims
- 3574US6063818ASubstituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 1997·Granted May 16, 2000·32 cites·47 claims
- 3672US9365528B2Derivatives of sulindac, use thereof and preparation thereofREYNOLDS ROBERT·Filed 2012·Granted Jun 14, 2016·2 cites·15 claims
- 3772US6391885B1Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivativesCELL PATHWAYS INC·Filed 2000·Granted May 21, 2002·2 cites·4 claims
- 3871US10039764B2Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expressionUNIV SOUTH ALABAMA·Filed 2014·Granted Aug 7, 2018·1 cites·8 claims
- 3971US5948779ASubstituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydesCELL PATHWAYS INC·Filed 1997·Granted Sep 7, 1999·13 cites·77 claims
- 4070US11834404B2Derivatives of sulindac can protect normal cells against oxidative damageUNIV SOUTH ALABAMA·Filed 2021·Granted Dec 5, 2023·0 cites·18 claims
- 4170US6066634ASubstituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted May 23, 2000·12 cites·28 claims
- 4268US5874440AMethod of treating a patient having precancerous lesions with phenyl pyrimidinone derivativesCELL PATHWAYS INC·Filed 1995·Granted Feb 23, 1999·27 cites·16 claims
- 4367US6500610B1Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compoundsCELL PATHWAYS INC·Filed 1999·Granted Dec 31, 2002·22 cites·12 claims
- 4467US6232312B1Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acidesCELL PATHWAYS INC·Filed 1998·Granted May 15, 2001·31 cites·14 claims
- 4567US5238965AMethods of using lysophosphatidic acids for regulating skin wrinklesPROCTER & GAMBLE·Filed 1991·Granted Aug 24, 1993·28 cites·16 claims
- 4666US6071934AIndenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jun 6, 2000·25 cites·4 claims
- 4766US6028116ASubstituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Feb 22, 2000·29 cites·52 claims
- 4866US5852035AMethod for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-aminesCELL PATHWAYS INC·Filed 1997·Granted Dec 22, 1998·28 cites·15 claims
- 4965US5942520AMethod for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 aminesCELL PATHWAYS INC·Filed 1998·Granted Aug 24, 1999·27 cites·15 claims
- 5064US6121321ASubstituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1996·Granted Sep 19, 2000·26 cites·23 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gary A. Piazza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →